Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
A randomized phase III study of gefitinib (IRESSATM) versus standard chemotherapy (gemcitabine plus cisplatin) as a first-line treatment for never-smokers with advanced or metastatic adenocarcinoma of the lung
- Authors
- Lee, Jin S.; Park, Keunchil; Kim, Sang-We; Lee, Dae Ho; Kim, Heung Tae; Han, Ji-Youn; Yun, Tak; Ahn, Myung-Ju; Ahn, Jin Seok; Suh, Cheolwon; Lee, Jung-Shin; Han, Jong Hee; Yu, Sun Young; Lee, Jae Won; Jo, SookJung
- Issue Date
- Sep-2009
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF THORACIC ONCOLOGY, v.4, no.9, pp.S283 - S284
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF THORACIC ONCOLOGY
- Volume
- 4
- Number
- 9
- Start Page
- S283
- End Page
- S284
- ISSN
- 1556-0864
- Files in This Item
- There are no files associated with this item.
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- LEE, JAE WON
- College of Political Science & Economics (Department of Statistics)